Epitome Holdings Private Limited's Insider Trades & SAST Disclosures

Show

Stock	Client Name	Client Category	Action*	Reported To/By Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Period	Regulation (Insider/SAST)	Security Type	Mode
Morepen Laboratories	Epitome Holdings Private Limited	Promoter Group	Acquisition	05 Apr 2022	3,500,000	14,500,820 (3.04%)	0.78%	25	87,500,000	30 Mar 2022 30 Mar 2022	Insider Trading	Equity Shares	Conversion of security
Morepen Laboratories	Epitome Holdings Private Limited	Promoter Group	Acquisition	01 Apr 2021	3,500,000	3,500,000 (0.72%)	0.78%	25	87,500,000	25 Mar 2021 25 Mar 2021	Insider Trading	Warrants	Preferential Offer

Showing 1 to 2 of 2 entries

*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.

View All The Insider Trades & SAST